Skip to main content
Home  >  Overview  >  Agenda

Agenda

Frankfurt / New York
16:30 / 10:30
Introduction
John Gilardi and Phoebe Loh Investor Relations team
16:34 / 10:34
Strategy update
Thierry Bernard Chief Executive Officer
17:00 / 11:00
COVID-19 response
Thierry Bernard Chief Executive Officer
Deep dive: Five pillars of growth
17:10 / 11:10
  • Sample technologies
  • QIAcuity digital PCR
Thomas Schweins Senior Vice President,
Life Sciences Business Area
17:30 / 11:30
  • NeuMoDx
  • QIAstat-Dx
  • QuantiFERON
Jean-Pascal Viola Senior Vice President,
Molecular Diagnostics Business Area
and Corporate Business Development
17:55 / 11:55
Financial update
Roland Sackers Chief Financial Officer
18:15 – 18:45 /
12:15 – 12:45
Q&A session
back to main event page